← All trials
NCT06480240
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 12, 2024
- Primary completion
- Jun 30, 2027
- Completion date
- Jun 30, 2027
- First posted
- Jun 28, 2024
- Last posted
- Jun 28, 2024
- Enrollment
- 117
- Arms / groups
- 10 / —
- Source
- AACT · ctgov ingestion
Sponsors
- OBI Pharma, IncLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.